Physician profile
Anand S Jain
NPI 1831489616
$13,045.09
in general payments reported to CMS, 2019-2025
8 companies · $4,005 in 2025
The $4,005 reported for 2025 was more than what 89% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $3,201 · 2022: $3,735 · 2023: $121 · 2024: $1,983 · 2025: $4,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,525 · Food and Beverage: $493 · Education: $91.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,525.00 |
| Food and Beverage | $493.10 |
| Education | $91.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,838.37 | 2023-2025 | Beacon, Barrx, Endoflip |
| Genzyme Corporation | $3,297.79 | 2022-2024 | |
| Covidien Lp | $2,010.74 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $1,727.61 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $91.02 | 2023-2025 | |
| Abbvie INC. | $79.56 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anand Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.